Related references
Note: Only part of the references are listed.A Pharmacogenetics Study in Mozambican Patients Treated with Nevirapine: Full Resequencing of TRAF3IP2 Gene Shows a Novel Association with SJS/TEN Susceptibility
Cinzia Ciccacci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Clinical features of and genetic predisposition to drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients-investigating the relation between the HLA -B*4403 allele and lamotrigine
Hye Jung Park et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Association of HLA-B*1502 allele with lamotrigine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese subjects: a meta-analysis
Tao Zeng et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2015)
Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy
Xiao-Jing He et al.
EPILEPSIA (2014)
HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis susceptibility in a population from Mozambique
Paola Borgiani et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations
Daniel F. Carr et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: Strength and clinical correlations
Yi-Hsin Hsiao et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2014)
HIV infection predisposes skin to toxic epidermal necrolysis via depletion of skin-directed CD4+ T cells
Chao Yang et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis
E. Genin et al.
PHARMACOGENOMICS JOURNAL (2014)
Detection of HLA-B☆58:01, the susceptible allele for allopurinol-induced hypersensitivity, by loop-mediated isothermal amplification
J. Kwok et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population
M. Goncalo et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunction
Balachandar Venkatesan et al.
CELLULAR SIGNALLING (2013)
Association of Human Leukocyte Antigen Alleles and Nevirapine Hypersensitivity in a Malawian HIV-Infected Population
Daniel F. Carr et al.
CLINICAL INFECTIOUS DISEASES (2013)
Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing
M. S. Hershfield et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese
Ying-Kit Cheung et al.
EPILEPSIA (2013)
Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics study
Cinzia Ciccacci et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Toxic epidermal necrolysis Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis
Robert A. Schwartz et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Phenobarbital-induced severe cutaneous adverse drug reactions are associated with CYP2C19*2 in Thai children
Wiparat Manuyakorn et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2013)
The role of Act1, a NF-κB-activating protein, in IL-6 and IL-8 levels induced by IL-17 stimulation in SW982 cells
Fang Lv et al.
PHARMACEUTICAL BIOLOGY (2013)
A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients
M. Tohkin et al.
PHARMACOGENOMICS JOURNAL (2013)
HLA-Dependent Hypersensitivity Reaction to Nevirapine in Chinese Han HIV-Infected Patients
Shicheng Gao et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2012)
Incidence of Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome in an HIV Cohort An Observational, Retrospective Case Series Study
Nicole Mittmann et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2012)
Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status?
M. H. Lee et al.
INTERNAL MEDICINE JOURNAL (2012)
Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome
Chun-Yu Wei et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25
Bo Zhong et al.
NATURE IMMUNOLOGY (2012)
HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications
Mayumi Ueta et al.
PLOS ONE (2012)
HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain
Kongkiat Kulkantrakorn et al.
PAIN PRACTICE (2012)
Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent
Jing Yuan et al.
AIDS (2011)
Association of HLA-B*5801 allele and allopurinol-induced stevens johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis
Ratchadaporn Somkrua et al.
BMC MEDICAL GENETICS (2011)
HLA-B*1502 genotyping in two Chinese patients with phenytoin-induced Stevens-Johnson syndrome
Fu-Li Min et al.
EPILEPSY & BEHAVIOR (2011)
Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans
Sae-Hoon Kim et al.
EPILEPSY RESEARCH (2011)
Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population
Takeshi Ozeki et al.
HUMAN MOLECULAR GENETICS (2011)
Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population
Choong-Chor Chang et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2011)
Stevens-Johnson syndrome induced by acetazolamide
Young Her et al.
JOURNAL OF DERMATOLOGY (2011)
IL-17R signaling: new players get in on the Act1
Michael J. May
NATURE IMMUNOLOGY (2011)
HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency
Jae-Woo Jung et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
Mark McCormack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Prostaglandin E Receptor Subtype EP3 Expression in Human Conjunctival Epithelium and Its Changes in Various Ocular Surface Disorders
Mayumi Ueta et al.
PLOS ONE (2011)
Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans
Hye-Ryun Kang et al.
PHARMACOGENETICS AND GENOMICS (2011)
Rapid screening for the detection of HLA-B57 and HLA-B58 in prevention of drug hypersensitivity
L. Kostenko et al.
TISSUE ANTIGENS (2011)
Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature
Kristina E. Ward et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2010)
HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients
Nahoko Kaniwa et al.
EPILEPSIA (2010)
Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population
Wichittra Tassaneeyakul et al.
EPILEPSIA (2010)
HLA Class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions
Hiroko Ikeda et al.
EPILEPSIA (2010)
Association between prostaglandin E receptor 3 polymorphisms and Stevens-Johnson syndrome identified by means of a genome-wide association study
Mayumi Ueta et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese
Shuen-Iu Hung et al.
PHARMACOGENOMICS (2010)
HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis
Sae-Hoon Kim et al.
PHARMACOGENOMICS (2010)
Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population
Xiang-qing Wang et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2010)
The clinical impact of pharmacogenetics on the treatment of epilepsy
Wolfgang Loescher et al.
EPILEPSIA (2009)
Cytochrome P450 2B6 516G→T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population
T. W. Mahungu et al.
HIV MEDICINE (2009)
Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians
Timir Y. Mehta et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2009)
Association of high T allele frequency of CYP2B6 G516T polymorphism among ethnic south Indian HIV-infected patients with elevated plasma efavirenz and nevirapine
Geetha Ramachandran et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients
Gbenga R. Kazeem et al.
PHARMACOGENETICS AND GENOMICS (2009)
Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population
Wichittra Tassaneeyakul et al.
PHARMACOGENETICS AND GENOMICS (2009)
HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients
Sirirat Likanonsakul et al.
AIDS Research and Therapy (2009)
Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population
Chaichon Locharernkul et al.
EPILEPSIA (2008)
Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients
Mariko Kashiwagi et al.
JOURNAL OF DERMATOLOGY (2008)
Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel
Sitna Halevy et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
Christine Lonjou et al.
PHARMACOGENETICS AND GENOMICS (2008)
HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis
Nahoko Kaniwa et al.
PHARMACOGENOMICS (2008)
Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations
P. Brent Ferrell et al.
PHARMACOGENOMICS (2008)
HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China
E. Trachtenberg et al.
TISSUE ANTIGENS (2007)
Human leukocyte antigens and drug hypersensitivity
Wen-Hung Chung et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome
Mayumi Ueta et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2007)
Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in han Chinese
Celeste B. L. Man et al.
EPILEPSIA (2007)
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial
Anthony G. Marson et al.
LANCET (2007)
Cytochrome P4502B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda
S. R. Penzak et al.
HIV MEDICINE (2007)
Toxic epidermal necrolysis
Frederick A. Pereira et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions
Shuen-Lu Hung et al.
PHARMACOGENETICS AND GENOMICS (2006)
HLA-A, -B, and-DRB1 polymorphism defined by sequence-based typing of the Han population in Northern China
G Yang et al.
TISSUE ANTIGENS (2006)
HLA-B locus in Caucasian patients with carbamazepine hypersensitivity
Ana Alfirevic et al.
PHARMACOGENOMICS (2006)
Toxic epidermal necrolysis with combination lamotrigine and valproate in bipolar disorder
CC Chang et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Toxic epidermal necrolysis (TEN) Lyell's syndrome
VN Sehgal et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2005)
Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature
E Letko et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2005)
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
SL Hung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study
F van Leth et al.
LANCET (2004)
Gene map of the extended human MHC
R Horton et al.
NATURE REVIEWS GENETICS (2004)
Functional characterization of cytochrome P4502B6 allelic variants
H Jinno et al.
DRUG METABOLISM AND DISPOSITION (2003)
A review of clinical trials to prevent mother-to-child HIV-1 transmission in Africa and inform rational intervention strategies
ML Nolan et al.
AIDS (2002)
Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children - A review of 10 years' experience
R Forman et al.
DRUG SAFETY (2002)
Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
JP Fagot et al.
AIDS (2001)
Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver
T Lang et al.
PHARMACOGENETICS (2001)
Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population
S Saito et al.
TISSUE ANTIGENS (2000)
Share Paper
